Summary of findings table ‐ immunostimulant vs placebo
Participants with no exacerbations in study period · adults with chronic bronchitis or chronic obstructive pulmonary disease
Summary of findings table ‐ immunostimulant probably leads to higher number of participants with no exacerbations during the study period compared with placebo (moderate certainty).
1 finding from 1 review
- Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive… 2022 · Cochrane Headline outcomes onlyOR 1.48 [1.15, 1.9]15 studies · 2961 participantsModerate